ABBV vs PFE — AbbVie Inc. vs Pfizer Inc. Performance & Valuation Comparison
Normalized returns over 2 years plus key valuation and risk snapshots.
QuantSoar AI Verdict
PFE is the better value pick
ABBV: $264.58 · Margin of Safety -30.0%|PFE: $28.57 · Margin of Safety -15.5%
Performance & Valuation Comparison
Normalized returns over 2 years plus key valuation and risk snapshots.
Loading performance data...
Fundamentals & Valuation Deep Dive
Side-by-side financial metrics and valuation models.
ABBVMetricPFE
$264.58Current Price$28.57
86.78Fair Value21.71
-67.2%Margin of Safety-24.0%
74.5P/E Ratio37.6
7.3P/S Ratio2.6
78.8P/B Ratio1.9
0.28Beta0.30
$467.5BMarket Cap$162.8B
0.03%Dividend Yield0.06%
9.8%Profit Margin6.8%
40.0%Operating Margin27.9%
—ROE5.0%
$61.2BRevenue$62.6B
16.3Forward P/E9.9
0.0Debt / Equity74.3
$278.56Analyst Target$28.88
financialProfile
AbbVie Inc.
Current Price$264.58
Fair Value$86.78
Margin of Safety-67.2%
P/E Ratio74.5
P/S Ratio7.3
P/B Ratio-78.8
Beta0.3
Dividend Yield0.03%
Profit Margin9.8%
Operating Margin40.0%
ROE—
Revenue$61.2B
Forward P/E16.3
Debt / Equity—
Analyst Target$278.56
Market Cap$467.5B
financialProfile
Pfizer Inc.
Current Price$28.57
Fair Value$21.71
Margin of Safety-24.0%
P/E Ratio37.6
P/S Ratio2.6
P/B Ratio1.9
Beta0.3
Dividend Yield0.06%
Profit Margin6.8%
Operating Margin27.9%
ROE5.0%
Revenue$62.6B
Forward P/E9.9
Debt / Equity74.3
Analyst Target$28.88
Market Cap$162.8B
Smart Investment Matcher
Input your budget and horizon. We simulate DCA backtests and recommend the best fit.
Loading smart matcher...
Final Verdict & Actionable Takeaways
Our quantitative verdict
PFE offers better risk-adjusted value
Based on margin of safety (PFE wins) and beta safety (ABBV wins).
Related Stock Comparisons
Explore other popular side-by-side matchups and sector peers.